Innoveren Scientific Statistics
Total Valuation
IVRN has a market cap or net worth of $33,825. The enterprise value is $4.37 million.
Important Dates
The last earnings date was Monday, August 19, 2024.
| Earnings Date | Aug 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IVRN has 6.77 million shares outstanding. The number of shares has increased by 152.30% in one year.
| Shares Outstanding | 6.77M |
| Shares Change (YoY) | +152.30% |
| Shares Change (QoQ) | -36.24% |
| Owned by Insiders (%) | 11.26% |
| Owned by Institutions (%) | n/a |
| Float | 5.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.77 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -253.59% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.63M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.09% in the last 52 weeks. The beta is 483.34, so IVRN's price volatility has been higher than the market average.
| Beta (5Y) | 483.34 |
| 52-Week Price Change | -99.09% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 56.06 |
| Average Volume (20 Days) | 762 |
Short Selling Information
The latest short interest is 294, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 294 |
| Short Previous Month | 275 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.01% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
| Revenue | n/a |
| Gross Profit | -999 |
| Operating Income | -2.09M |
| Pretax Income | -7.28M |
| Net Income | -3.26M |
| EBITDA | -2.08M |
| EBIT | -2.09M |
| Earnings Per Share (EPS) | -$5.51 |
Full Income StatementBalance Sheet
The company has $543,882 in cash and $4.44 million in debt, giving a net cash position of -$3.89 million or -$0.58 per share.
| Cash & Cash Equivalents | 543,882 |
| Total Debt | 4.44M |
| Net Cash | -3.89M |
| Net Cash Per Share | -$0.58 |
| Equity (Book Value) | -10.89M |
| Book Value Per Share | -15.91 |
| Working Capital | -8.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | -918,105 |
| Capital Expenditures | n/a |
| Free Cash Flow | -918,105 |
| FCF Per Share | -$0.14 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -272.06% |